In 2018 the Cure4 Cystic Fibrosis Foundation (C4CF) made a strategic decision to partner with the National Foundation for Medical Research and Innovation (NFMRI) to manage and administer grants on their behalf with the first call for expressions of interest commencing in 2019.
The partnership provided $460K to advance medical innovations in the area of cystic fibrosis and grants were named the Cure4 Cystic Fibrosis Foundation – Barbara Stow-Smith CF Innovation Grant‘, in honour of the Foundation’s first bequest.
Utilising NFMRI’s successful strategy, and unique capability and capacity the partnership sought to fund research that seeks to develop therapies or cures that will result in an increase in average life expectancy of people with cystic fibrosis with consideration given to quality of life.
Executive Manager, Suzy Dimaline said, ‘A partnership with NFRMI allowed Cure4 Cystic Fibrosis to expand its grant program to the national scientific research community. The expert assessment of the Research Advisory Committee and the broad reach of the NFMRI grant program to universities and medical research institutes across Australia, meant that Cure4 Cystic Fibrosis could achieve a long-desired ambition to fund the best CF research initiatives across the country. NFMRI’s focus on translation and collaboration is key to producing outcomes that benefits the cystic fibrosis community and we look forward to sharing learnings with our supporters and partners.’
All funding from this partnership has already been committed.
